184 related articles for article (PubMed ID: 16099702)
1. DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals.
Sigurdson AJ; Hauptmann M; Alexander BH; Doody MM; Thomas CB; Struewing JP; Jones IM
Mutat Res; 2005 Oct; 586(2):173-88. PubMed ID: 16099702
[TBL] [Abstract][Full Text] [Related]
2. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD).
Starcevic SL; Diotte NM; Zukowski KL; Cameron MJ; Novak RF
Toxicol Sci; 2003 Sep; 75(1):74-81. PubMed ID: 12805649
[TBL] [Abstract][Full Text] [Related]
3. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment of renal cell carcinoma using alkaline comet assay.
Lin X; Wood CG; Shao L; Huang M; Yang H; Dinney CP; Wu X
Cancer; 2007 Jul; 110(2):282-8. PubMed ID: 17549681
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment of oral cancer in patients with pre-cancerous states of the oral cavity using micronucleus test and challenge assay.
Saran R; Tiwari RK; Reddy PP; Ahuja YR
Oral Oncol; 2008 Apr; 44(4):354-60. PubMed ID: 17936677
[TBL] [Abstract][Full Text] [Related]
6. DNA damage levels in prostate cancer cases and controls.
Lockett KL; Hall MC; Clark PE; Chuang SC; Robinson B; Lin HY; Su LJ; Hu JJ
Carcinogenesis; 2006 Jun; 27(6):1187-93. PubMed ID: 16364923
[TBL] [Abstract][Full Text] [Related]
7. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
[TBL] [Abstract][Full Text] [Related]
8. DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.
Sánchez-Suárez P; Ostrosky-Wegman P; Gallegos-Hernández F; Peñarroja-Flores R; Toledo-García J; Bravo JL; Del Castillo ER; Benítez-Bribiesca L
Mutat Res; 2008 Apr; 640(1-2):8-15. PubMed ID: 18207203
[TBL] [Abstract][Full Text] [Related]
9. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.
Kennedy DO; Agrawal M; Shen J; Terry MB; Zhang FF; Senie RT; Motykiewicz G; Santella RM
J Natl Cancer Inst; 2005 Jan; 97(2):127-32. PubMed ID: 15657342
[TBL] [Abstract][Full Text] [Related]
10. Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay.
Shahidi M; Mozdarani H; Bryant PE
Cancer Lett; 2007 Nov; 257(2):263-73. PubMed ID: 17881118
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
12. DNA breaks as measured by the alkaline comet assay in exfoliated cells as compared to voided urine cytology in the diagnosis of bladder cancer: a study of 105 subjects.
Fracasso ME; Franceschetti P; Doria D; Talamini G; Bonetti F
Mutat Res; 2004 Nov; 564(1):57-64. PubMed ID: 15474411
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced DNA damage and repair in peripheral blood mononuclear cells from Nijmegen breakage syndrome patients and carriers assessed by the Comet assay.
Bürger S; Schindler D; Fehn M; Mühl B; Mahrhofer H; Flentje M; Hoehn H; Seemanová E; Djuzenova CS
Environ Mol Mutagen; 2006 May; 47(4):260-70. PubMed ID: 16470524
[TBL] [Abstract][Full Text] [Related]
14. New measure of DNA repair in the single-cell gel electrophoresis (comet) assay.
Kim BS; Park JJ; Edler L; Von Fournier D; Haase W; Sautter-Bihl ML; Gotzes F; Thielmann HW
Environ Mol Mutagen; 2002; 40(1):50-6. PubMed ID: 12211076
[TBL] [Abstract][Full Text] [Related]
15. Differences in repair of DNA cross-links between lymphocytes and epithelial tumor cells from colon cancer patients measured in vitro with the comet assay.
Herrera M; Dominguez G; Garcia JM; Peña C; Jimenez C; Silva J; Garcia V; Gomez I; Diaz R; Martin P; Bonilla F
Clin Cancer Res; 2009 Sep; 15(17):5466-72. PubMed ID: 19690199
[TBL] [Abstract][Full Text] [Related]
16. Study on the relation between occupational fenvalerate exposure and spermatozoa DNA damage of pesticide factory workers.
Bian Q; Xu LC; Wang SL; Xia YK; Tan LF; Chen JF; Song L; Chang HC; Wang XR
Occup Environ Med; 2004 Dec; 61(12):999-1005. PubMed ID: 15550606
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928
[TBL] [Abstract][Full Text] [Related]
18. Family history of benign thyroid disease and cancer and risk of thyroid cancer.
Memon A; Berrington De González A; Luqmani Y; Suresh A
Eur J Cancer; 2004 Mar; 40(5):754-60. PubMed ID: 15010077
[TBL] [Abstract][Full Text] [Related]
19. Determination of DNA damage by alkaline halo and comet assay in patients under sevoflurane anesthesia.
Kadioglu E; Sardas S; Erturk S; Ozatamer O; Karakaya AE
Toxicol Ind Health; 2009 Apr; 25(3):205-12. PubMed ID: 19482915
[TBL] [Abstract][Full Text] [Related]
20. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer.
Blasiak J; Arabski M; Krupa R; Wozniak K; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Zadrozny M
Mutat Res; 2004 Oct; 554(1-2):139-48. PubMed ID: 15450412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
